Medplus Health Services Ltd (MEDPLUS)
₹660.55
Mkt cap
₹8,125 Cr
P/E ratio
38.60
P/B
4.00
Div yield
0.00%
ROE
11.60%
ROCE
12.60%
EPS (TTM)
₹17.11
Book value
₹165
52W range
649–954
Sector
Consumer Discretionary
Price history
Previous close
Medplus Health · Mkt Cap: 8,125 Crore (down -18.8% in 1 year) · Revenue: 7,229 Cr · Profit: 210 Cr · Stock is trading at 4.11 times its book value · Though the company is reporting repeated profits, it is not paying out dividend · Promoter Holding: 40.2%
NSE MEDPLUSBSE 543427
Health check
Mixed
ValuationCheap
ProfitabilityAverage
GrowthModerate
TechnicalsBearish
52-week range
−30.75% from high₹661
₹649+1.73% from low₹954
Current
₹660.55
Prev close
₹663.05
Day
−0.38%
Price performance
1D
−0.38%
1W
−1.74%
1M
−5.67%
3M
−23.28%
6M
−18.95%
1Y
−20.71%
YTD
−18.27%
Financials
Revenue, profit & margin
P/E ratio
38.6×
MEDPLUS is 23% below the sector median of 50.1×
MEDPLUS38.6×
Sector median50.1×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,284 | 1,409 | 1,441 | 1,490 | 1,489 | 1,576 | 1,561 | 1,510 | 1,543 | 1,679 | 1,806 | 1,864 | 1,880 | |
| Expenses | 1,213 | 1,324 | 1,350 | 1,385 | 1,395 | 1,452 | 1,429 | 1,373 | 1,412 | 1,530 | 1,648 | 1,695 | 1,746 | |
| Operating Profit | 71 | 85 | 92 | 106 | 94 | 124 | 133 | 136 | 131 | 149 | 159 | 169 | 133 | |
| OPM % | 6% | 6% | 6% | 7% | 6% | 8% | 8% | 9% | 8% | 9% | 9% | 9% | 7% | |
| Other Income | 9 | 10 | 10 | 10 | 9 | 12 | 13 | 16 | 15 | 17 | 18 | 21 | 20 | |
| Interest | 23 | 24 | 24 | 25 | 25 | 25 | 26 | 27 | 27 | 29 | 31 | 33 | 33 | |
| Depreciation | 52 | 55 | 57 | 59 | 60 | 63 | 62 | 64 | 66 | 69 | 73 | 76 | 78 | |
| Profit before tax | 5 | 16 | 20 | 32 | 18 | 48 | 57 | 61 | 53 | 69 | 73 | 80 | 42 | |
| Tax % | 26% | 12% | 31% | -5% | 19% | 19% | 19% | 16% | 20% | 19% | 21% | 20% | 21% | |
| Net Profit | 4 | 15 | 14 | 34 | 14 | 39 | 46 | 51 | 42 | 56 | 58 | 64 | 33 | |
| EPS in Rs | 0.32 | 1.22 | 1.15 | 2.79 | 1.20 | 3.24 | 3.83 | 4.29 | 3.54 | 4.63 | 4.82 | 5.33 | 2.76 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
No reaction history yet.
No quarterly filings ingested yet.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Jun 202640.19%Promoter
Promoters40.19%0.03
FIIs14.38%1.15
DIIs29.95%2.13
Public15.45%0.96
Ownership trend
Filings
Annual reports6
Concall transcripts46
TranscriptJul 2026PPTJul 2026RECJul 2026PPTJul 2026TranscriptMay 2026PPTMay 2026RECMay 2026TranscriptFeb 2026PPTFeb 2026RECFeb 2026TranscriptNov 2025PPTNov 2025TranscriptAug 2025PPTAug 2025RECAug 2025TranscriptMay 2025PPTMay 2025RECMay 2025TranscriptFeb 2025PPTFeb 2025TranscriptNov 2024PPTNov 2024RECNov 2024TranscriptAug 2024
Announcements5
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011. 26 AugDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 26 AugDisclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 21 AugDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 21 AugShareholder Meeting / Postal Ballot-Scrutinizer''s Report 18 Aug